Sanofi builds on mR­NA al­liances with an $805M pact for Ron Re­naud’s Trans­late Bio

A year af­ter Ron Re­naud’s team at RaNA bagged rights to an RNA plat­form at Shire and re­launched as Trans­late Bio, the group has scored a big phar­ma al­liance with Sanofi.

The French gi­ant is hand­ing over a $45 mil­lion up­front to part­ner with Trans­late, which will now set out to de­vel­op mes­sen­ger RNA vac­cines for up to 5 tar­gets. Trans­late will al­so be in line for up to $760 mil­lion in mile­stone cash if the work proves suc­cess­ful.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.